Taj Pharmaceuticals Company Profile
The company's Generics portfolio includes approximately 600 medications in gastroenterology, cardiology, pain management, oncology, anti-infective, pediatrics, and dermatology therapeutic areas.
Taj Pharmaceuticals
Pharmaceuticals
- Type
Public
- Headquarters
India
- Establishment
2004
- Key Management
Mr.Abhishek Kumar Singh (CEO)
- Revenue
~548(2021)
- Headcount
~2,726(2021)
- Website
Business Description
Taj Pharmaceuticals Ltd. is a generic pharmaceutical company that manufactures and develops drug dosages with diversified expertise. The company has eight manufacturing sites. The company sells more than 500+ generics and 100+ branded compositions to consumers in over 28 countries and territories in the world. The company offers a range of delivery systems and dosage forms including oral solids, sterile, injectable, liquids, transdermal, high-potency, and semi-solids products.
The company’s Generics portfolio includes approximately 600 medications in gastroenterology, cardiology, pain management, oncology, anti-infective, pediatrics, and dermatology therapeutic areas. Brands such as Alzocum, Benacof, Wallbrurate, Covers, Carol, Humogen, Merokem, and others are market leaders in India, Russia, and other CIS nations. In the semi-regulated markets of South America, North America, Africa, the Balkan countries, and other Asian countries, the company’s generics solutions deliver quality at cost-effective prices.
Key Financials
Revenue (US$ Mn):
Operating Income (US$ Mn):
Net Income(US$Mn):
Operating Margin %:
Gross Margin %:
SWOT Analysis
Strengths
Get this premium content
